Application of COP vial in recombinant protein drugs

Recombinant protein drugs are products expressed by genetic engineering technology to make up for the lack of certain functional proteins in the human body. These drugs have high protein content and are mostly packaged in glass bottles. However, glass has protein adsorption properties. How to improve the accuracy of the dosage of these drugs has become a problem that pharmaceutical companies need to consider. The emergence of plastic COP vials makes this The problem is solved.

COP vial

With the advancement of drug production technology and the increase in drug demand, the types of recombinant protein drugs in China continue to be enriched. At present, China's recombinant protein drugs mainly include: recombinant insulin, recombinant interferon, recombinant blood coagulation factor, recombinant erythropoietin, recombinant granulocyte colony Stimulating factors, enzymes instead of recombinant protein drugs, recombinant growth hormones, etc. Among them, recombinant insulin occupies an important position in China's recombinant protein drug market. Subdivided products such as recombinant interferon and recombinant erythropoietin have great development potential, especially long-acting drugs.

COP vilal is a new type of drug packaging. This material has the characteristics of low protein adsorption, high transparency, high rigidity, and good water vapor airtightness, and it meets FDA standards. Although the cost of the COP bottle is relatively higher than that of the glass bottle, the glass bottle will absorb a part of the drug, which means that the pharmaceutical company must fill more doses to ensure the accuracy of the patient's dosage. Recombinant protein drugs are high value-added drugs, and the extra dose has far exceeded the investment of pharmaceutical companies in packaging. Therefore, no matter from the characteristics of the drug or the overall cost, the COP vial is the best choice for protein drugs.

In foreign countries, the application of COP vial in the packaging of anti-cancer drugs and anti-tumor drugs has been very mature. With the acceleration of the development of innovative drugs in my country, this kind of packaging will also be more commonly used in China.